Mick Mulvaney reportedly received 2 coronavirus tests, despite not showing any symptoms

Mick Mulvaney, the former acting White House chief of staff, was tested twice for coronavirus despite exhibiting no symptoms, The Washington Post reports.
Mulvaney was first tested in February. He was scheduled to accompany President Trump on his visit to India, but prior to leaving said he felt sick. Although the test came back negative, Mulvaney did not join Trump on the trip. He was tested again this month after his niece, who shares an apartment with him, showed COVID-19 coronavirus symptoms after visiting Mar-a-Lago and meeting members of a Brazilian delegation who later tested positive for the virus, the Post reports.
During an appearance at the Conservative Political Action Conference (CPAC) in late February, Mulvaney tried to downplay the seriousness of COVID-19, saying it is "not a death sentence" and was being exaggerated because the media thinks "this will bring down the president."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In addition to Mulvaney, two other people close to Trump have been tested for coronavirus despite not showing any symptoms; Mark Meadows, his new acting White House chief of staff, and Rep. Matt Gaetz (R-Fla.). Gaetz and Meadows came into contact with a person at CPAC who was later diagnosed with COVID-19, and the White House medical office arranged their tests because of the possibility they could infect Trump, the Post says.
Federal health officials have said only people who are seriously ill should receive COVID-19 tests, and because of shortages, the United States is testing at a rate of just 0.12 percent, the Post reports. People who have been exposed to COVID-19 are being told to stay at home, take their temperature twice a day, and monitor for any symptoms. Read more at The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Today's political cartoons - February 22, 2025
Cartoons Saturday's cartoons - bricking it, I can buy myself flowers, and more
By The Week US Published
-
5 exclusive cartoons about Trump and Putin negotiating peace
Cartoons Artists take on alternative timelines, missing participants, and more
By The Week US Published
-
The AI arms race
Talking Point The fixation on AI-powered economic growth risks drowning out concerns around the technology which have yet to be resolved
By The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published